CN116350553A - Herbal alopecia preventing essence and preparation method thereof - Google Patents
Herbal alopecia preventing essence and preparation method thereof Download PDFInfo
- Publication number
- CN116350553A CN116350553A CN202310052278.2A CN202310052278A CN116350553A CN 116350553 A CN116350553 A CN 116350553A CN 202310052278 A CN202310052278 A CN 202310052278A CN 116350553 A CN116350553 A CN 116350553A
- Authority
- CN
- China
- Prior art keywords
- extract
- vitamin
- herbal
- alopecia
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000004384 Alopecia Diseases 0.000 title claims abstract description 53
- 231100000360 alopecia Toxicity 0.000 title claims abstract description 36
- 230000003405 preventing effect Effects 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims description 31
- 239000000284 extract Substances 0.000 claims abstract description 78
- 239000002994 raw material Substances 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 230000000694 effects Effects 0.000 claims abstract description 18
- 241000756943 Codonopsis Species 0.000 claims abstract description 14
- 235000019156 vitamin B Nutrition 0.000 claims abstract description 13
- 239000011720 vitamin B Substances 0.000 claims abstract description 13
- 229940046001 vitamin b complex Drugs 0.000 claims abstract description 13
- 102000008186 Collagen Human genes 0.000 claims abstract description 11
- 108010035532 Collagen Proteins 0.000 claims abstract description 11
- 229920001436 collagen Polymers 0.000 claims abstract description 11
- 235000015097 nutrients Nutrition 0.000 claims abstract description 10
- 239000000419 plant extract Substances 0.000 claims abstract description 10
- 241000717739 Boswellia sacra Species 0.000 claims abstract description 7
- 239000004863 Frankincense Substances 0.000 claims abstract description 7
- 241000628997 Flos Species 0.000 claims abstract description 5
- 241001057584 Myrrha Species 0.000 claims abstract description 5
- 239000009188 angelicae sinensis extract Substances 0.000 claims abstract description 5
- 229920001184 polypeptide Polymers 0.000 claims abstract description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 4
- 244000178870 Lavandula angustifolia Species 0.000 claims abstract description 3
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims abstract description 3
- 239000004909 Moisturizer Substances 0.000 claims abstract 2
- 230000001333 moisturizer Effects 0.000 claims abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 27
- 238000003756 stirring Methods 0.000 claims description 26
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 18
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 18
- 239000008213 purified water Substances 0.000 claims description 17
- 238000001816 cooling Methods 0.000 claims description 16
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 claims description 11
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 claims description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 9
- 108010020346 Polyglutamic Acid Proteins 0.000 claims description 9
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 9
- 229920002125 Sokalan® Polymers 0.000 claims description 9
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 9
- 229930003427 Vitamin E Natural products 0.000 claims description 9
- 235000010323 ascorbic acid Nutrition 0.000 claims description 9
- 229960005070 ascorbic acid Drugs 0.000 claims description 9
- 239000011668 ascorbic acid Substances 0.000 claims description 9
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 9
- 229960001631 carbomer Drugs 0.000 claims description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 9
- 229940069445 licorice extract Drugs 0.000 claims description 9
- 229940081859 myrrh extract Drugs 0.000 claims description 9
- 229920002643 polyglutamic acid Polymers 0.000 claims description 9
- 229940119485 safflower extract Drugs 0.000 claims description 9
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 9
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 9
- 235000019165 vitamin E Nutrition 0.000 claims description 9
- 239000011709 vitamin E Substances 0.000 claims description 9
- 229940046009 vitamin E Drugs 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 8
- 238000004806 packaging method and process Methods 0.000 claims description 8
- 238000007789 sealing Methods 0.000 claims description 8
- 229940107117 verbena extract Drugs 0.000 claims description 8
- 229920000057 Mannan Polymers 0.000 claims description 6
- LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 claims description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 241001530056 Athelia rolfsii Species 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 239000003906 humectant Substances 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 2
- 229930003451 Vitamin B1 Natural products 0.000 claims description 2
- 229930003779 Vitamin B12 Natural products 0.000 claims description 2
- 229930003471 Vitamin B2 Natural products 0.000 claims description 2
- 229930003537 Vitamin B3 Natural products 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 229960003512 nicotinic acid Drugs 0.000 claims description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 2
- 229940055726 pantothenic acid Drugs 0.000 claims description 2
- 235000019161 pantothenic acid Nutrition 0.000 claims description 2
- 239000011713 pantothenic acid Substances 0.000 claims description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- 229960003495 thiamine Drugs 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- 235000010374 vitamin B1 Nutrition 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 235000019163 vitamin B12 Nutrition 0.000 claims description 2
- 239000011715 vitamin B12 Substances 0.000 claims description 2
- 235000019164 vitamin B2 Nutrition 0.000 claims description 2
- 239000011716 vitamin B2 Substances 0.000 claims description 2
- 235000019160 vitamin B3 Nutrition 0.000 claims description 2
- 239000011708 vitamin B3 Substances 0.000 claims description 2
- 235000019158 vitamin B6 Nutrition 0.000 claims description 2
- 239000011726 vitamin B6 Substances 0.000 claims description 2
- 229940011671 vitamin b6 Drugs 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims 2
- 244000061520 Angelica archangelica Species 0.000 claims 1
- 235000001287 Guettarda speciosa Nutrition 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 210000004209 hair Anatomy 0.000 abstract description 27
- 210000004761 scalp Anatomy 0.000 abstract description 14
- 230000007794 irritation Effects 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 238000011160 research Methods 0.000 abstract description 3
- 239000012676 herbal extract Substances 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 230000008326 skin blood flow Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 24
- 238000012360 testing method Methods 0.000 description 16
- 239000003814 drug Substances 0.000 description 12
- 229940079593 drug Drugs 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 9
- 241000382455 Angelica sinensis Species 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 210000003780 hair follicle Anatomy 0.000 description 7
- 230000003779 hair growth Effects 0.000 description 7
- 229940075000 frankincense extract Drugs 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 244000182067 Fraxinus ornus Species 0.000 description 3
- 235000002917 Fraxinus ornus Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000005260 corrosion Methods 0.000 description 3
- 230000003803 hair density Effects 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229940064221 ligusticum wallichii root extract Drugs 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010034972 Photosensitivity reaction Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000003648 hair appearance Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 208000007578 phototoxic dermatitis Diseases 0.000 description 2
- 231100000018 phototoxicity Toxicity 0.000 description 2
- 230000036619 pore blockages Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000003797 telogen phase Effects 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010044625 Trichorrhexis Diseases 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000018718 Verbena officinalis Nutrition 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 231100000005 chromosome aberration Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 210000002768 hair cell Anatomy 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000007886 mutagenicity Effects 0.000 description 1
- 231100000299 mutagenicity Toxicity 0.000 description 1
- 231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 238000010181 skin prick test Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
The invention provides herbal alopecia preventing essence, which comprises, by mass, 0.27-11.10% of plant extracts, 0.26-6.10% of nutrient elements, 1.51-21.00% of moisturizers, and the balance of water; the plant extract comprises extract of herba Apocyni Veneti Hu Suogen, carthami flos extract, radix Codonopsis Lanceolatae extract, radix Angelicae sinensis extract, rhizoma Ligustici Chuanxiong root extract, olibanum extract, myrrha extract, glycyrrhrizae radix extract, herba Verbenae extract, and oleum Lavandula Angustifolia. The invention is prepared by combining natural herbal plant extracts as main efficacy raw materials with biotechnology and performing multi-disciplinary cross research, and has mild effect on scalp, small irritation and high safety; through the mutual synergistic effect of herbal extract, vitamin B complex, hydrolyzed collagen, biological polypeptide and other nutrients, the hair and skin blood circulation is promoted, scalp nutrition is supplemented, scalp microenvironment is improved, and scalp maintains good growth state, so that alopecia is effectively prevented.
Description
Technical Field
The invention relates to herbal alopecia preventing essence and a preparation method thereof.
Background
In the past, hair plays an important role in the instrument of the appearance of a human body, and meanwhile, from the perspective of traditional Chinese medicine, hair is also an important index of the health condition of the human body. Hair grows from subcutaneous hair follicles of the head, and the hair growth has periodicity, i.e., it is divided into a growing period, a retrograde period and a resting period, and the hair in the growing period accounts for about 85% of all the hair, and the hair grows by 0.27-0.4 mm per day. The growing period of the hair is 2-6 years, and after entering the retreating period, the hair bulb at the lower part of the hair follicle including the hair growing part starts to shrink. Hair does not grow and becomes loose and is easy to fall off; hair in the retrograde phase accounts for about 1%; in telogen phase, hair follicle lower part is completely atrophic, hair falls off, and hair in telogen phase accounts for about 14%; the resting period lasts for 3-6 months, and then the hair follicle is grown into the growing period and a new hair grows. In recent years, along with the acceleration of the life rhythm, people often overtime and stay up with high life pressure and irregular life, so that health problems are caused, hair quality is affected, and the problems of poor hair quality, dryness, easy falling and the like are often caused. The number of patients with alopecia increases year by year and tends to be younger, and the proportion of men aged 20 to 40 years has a problem of alopecia as high as 40% or more.
The root cause of alopecia is ecological damage of scalp, pore blockage, atrophy and degeneration of hair follicle, and cell atrophy and even necrosis in hair follicle caused by excessive secretion of grease, blockage of hair pore and the like, so that the hair cannot absorb nutrients of surrounding hair, and hair does not grow any more. Under normal conditions, hair papilla in hair follicle has abundant capillary vessels, which can absorb nutrients necessary for hair growth from blood, and ensure normal hair growth. The hair falls off by metabolism by about 50-100 pieces per day, but the whole quantity of the hair is not affected. However, the normal growth environment of the hair is destroyed due to the excessive secretion of sebaceous glands, pore blockage and the like, so that the hair cannot grow normally, and phenomena such as alopecia, hair breakage and the like can occur.
At present, the drugs for treating alopecia and promoting hair growth on the market are more and messy, and the research on the cause of alopecia is not thorough, so that the existing drugs for stopping alopecia and promoting hair growth can not treat both principal and secondary aspect of disease, and the drugs are high in price, large in irritation to scalp, unsatisfactory in effect and side effects. How to obtain a natural mild product for preventing alopecia is a technical problem which needs to be solved in the current field.
Disclosure of Invention
The invention aims to overcome the defects of the prior art, provides herbal alopecia preventing essence and a preparation method thereof, and provides a safe, effective and stable alopecia preventing product.
In order to solve the technical problems, the invention adopts the following technical scheme: an herbal alopecia preventing essence comprises, by mass, 0.27-11.10% of plant extract, 0.26-6.10% of nutrient elements, 1.51-21.00% of humectant, and the balance of water;
the plant extract comprises extract of herba Apocyni Veneti Hu Suogen, carthami flos extract, radix Codonopsis Lanceolatae extract, radix Angelicae sinensis extract, rhizoma Ligustici Chuanxiong root extract, olibanum extract, myrrha extract, glycyrrhrizae radix extract, herba Verbenae extract, and oleum Lavandula Angustifolia.
Further, the plant extract comprises, by mass, 0.1-2% of a tooth petal delay Hu Suogen extract, 0.1-2% of a safflower extract, 0.01-1% of a radix codonopsis pilosulae root extract, 0.01-1% of a angelica sinensis extract, 0.01-1% of a ligusticum wallichii root extract, 0.01-1% of a olibanum extract, 0.01-1% of a myrrh extract, 0.01-1% of a licorice extract, 0.01-1% of a verbena extract and 0.001-0.1% of lavender oil.
Further, the nutrient elements comprise, by mass, 0.1-2% of sodium hyaluronate, 0.05-1% of vitamin E,0.1-2% of palmitoyl pentapeptide-4, 0.01-1% of mannans and 0.001-0.1% of vitamin B complex.
Further, the vitamin B complex comprises biotin, folic acid, vitamin B12, vitamin B3, pantothenic acid, vitamin B6, vitamin B2, vitamin B1 and yeast polypeptides.
Further, the humectant comprises 1-10% of butanediol, 0.1-2% of polyglutamic acid, 0.1-2% of hydrolyzed micronucleus, 0.01-1% of hydrolyzed collagen, 0.1-2% of ascorbic acid, 0.1-2% of glycerol and 0.1-2% of triethanolamine by mass fraction.
Further, the paint also comprises 0.1-2% of thickener by mass, wherein the thickener is carbomer.
Further, the anti-corrosion agent comprises 0.1-2% of anti-corrosion agent by mass, wherein the anti-corrosion agent is p-hydroxyacetophenone.
Further, the preparation method of the herbal alopecia preventing essence comprises the following steps:
s1, adding required purified water into a preparation tank, pouring weighed A-phase raw materials into the preparation tank, uniformly stirring, heating the prepared solution to above 70 ℃, and preserving heat for 30min; the A phase raw material comprises carbomer;
s2, gradually cooling, sequentially pouring the weighed B-phase raw materials, the weighed C-phase raw materials and the balance of purified water, and uniformly stirring;
the B phase raw materials comprise butanediol, sodium hyaluronate, p-hydroxyacetophenone, polyglutamic acid, hydrolyzed sclerotium rolfsii and vitamin E;
the C phase material comprises tooth petal Hu Suogen extract, carthami flos extract, radix Codonopsis Lanceolatae extract, radix Angelicae sinensis extract, rhizoma Ligustici Chuanxiong root extract, olibanum extract, myrrha extract, glycyrrhrizae radix extract, and herba Verbenae extract;
s3, further cooling, sequentially pouring the weighed D-phase raw materials and the weighed E-phase raw materials, uniformly stirring, packaging and sealing to obtain a herbal alopecia-preventing essence finished product with a alopecia-preventing effect;
the phase D comprises hydrolyzed collagen, palmitoyl pentapeptide-4, ascorbic acid, glycerol, mannans and vitamin B complex;
the E phase comprises triethanolamine and lavender oil.
Compared with the prior art, the invention has the beneficial effects that: the herbal extract is used as a main efficacy raw material and is combined with biotechnology, and the hair tonic is prepared through multi-disciplinary cross research, and has the advantages of mild effect on scalp, small irritation and high safety; through the synergistic interaction of the plant extract, the vitamin B complex, the hydrolyzed collagen, the biological polypeptide and other nutrients, the blood circulation of the head skin is promoted, the nutrition of the scalp is supplemented, the microenvironment of the scalp is improved, and the scalp is kept in a good growth state, so that the alopecia is effectively prevented.
Detailed Description
It is to be understood that, according to the technical solution of the present invention, those skilled in the art may propose various alternative structural modes and implementation modes without changing the true spirit of the present invention. Accordingly, the following detailed description is merely illustrative of the invention and should not be taken as an exhaustive or limiting example of the invention.
A herbal baldness-preventing essence consists of purified water, an A phase, a B phase, a C phase, a D phase and an E phase, wherein the components and the weight ratio thereof are as follows:
the principle of the invention is as follows:
angelica sinensis extract: can dilate skin capillary vessel, promote blood circulation, promote hair growth, and nourish hair; can promote blood circulation and enrich blood, and can improve the conditions of hair loss, dark yellow color and the like caused by deficiency of qi and blood; rich in trace elements, and can nourish skin and prevent roughness.
Efficacy of the Boswellia carterii extract: has remarkable anti-inflammatory, blood circulation promoting and blood stasis removing effects;
efficacy effect of myrrh extract: has effects in promoting blood circulation, dispelling blood stasis, relieving inflammation and pain, resisting bacteria, relieving swelling, and promoting granulation;
efficacy of safflower extract: has effects of relieving inflammation, promoting blood circulation, dredging channels, removing blood stasis, and relieving pain;
tooth clack delay Hu Suogen extract: has effects of promoting blood circulation, dispelling blood stasis, activating qi-flowing, relieving pain, and tranquilizing.
Ligusticum wallichii root extract: has effects of promoting blood circulation, activating qi-flowing, dispelling pathogenic wind, and relieving pain.
Radix codonopsis pilosulae root extract: contains sterol, radix Codonopsis glycoside and alkaloid, has effects of invigorating spleen and replenishing qi, invigorating spleen and replenishing lung, and can be used for treating deficiency of both qi and blood, and regulating skin.
Efficacy of licorice extract: has effects of invigorating spleen, replenishing qi, clearing heat, detoxicating, eliminating phlegm, relieving cough, relieving spasm, relieving pain, and harmonizing the medicines.
Vervain extract: has effects in relieving inflammation and pain, stopping bleeding, and inhibiting bacteria.
Lavender oil: has antibacterial and antiinflammatory effects.
The angelica sinensis extract is a monarch drug in the formula, plays a main treatment role, can dilate skin capillaries, quickens blood circulation, and has the effects of promoting hair growth and nourishing hair; the frankincense extract, the myrrh extract, the safflower extract, the tooth petal delay Hu Suogen extract and the ligusticum wallichii root extract are ministerial drugs in the formula and assist the monarch drugs to play a role; the radix codonopsis pilosulae root extract is used as an adjuvant drug in the formula and is used for assisting monarch and ministerial drugs in treating main symptoms and treating concurrent symptoms; the licorice extract, the verbena extract and the lavender oil are used as guiding drugs in the formula, diminishing inflammation, sterilizing, improving the scalp ecology and guiding the drugs to exert the maximum efficacy.
The invention organically combines the raw materials, has reasonable formula, plays a synergistic effect well, promotes scalp blood circulation, inhibits bacteria and resists inflammation, simultaneously permeates various nutrient substances and moisturizing components into skin tissues, improves the environment ecology of the skin of the head, supplements scalp nutrition, and enables the scalp to keep a good growth state, thereby playing the role of preventing alopecia.
The preparation method comprises the following steps:
s1, weighing all required raw materials according to a formula;
s2, adding the required purified water amount into a preparation tank, pouring the weighed A-phase raw materials into the preparation tank, covering a preparation tank cover, uniformly stirring, heating the preparation solution to above 70 ℃, and preserving heat for 30 minutes;
s3, gradually cooling, sequentially pouring the weighed B-phase raw materials and C-phase raw materials, covering a prepared tank cover, and uniformly stirring; pouring the required residual purified water and uniformly stirring;
s4, cooling, pouring the weighed D-phase raw materials, uniformly stirring, pouring the weighed E-phase raw materials, covering a preparation tank cover, and uniformly stirring;
s5, packaging and sealing to obtain the herbal alopecia preventing essence product with the alopecia preventing effect.
The technical effects of the present application are further described below with reference to examples.
Example 1
A preparation method of herbal anti-alopecia essence comprises the following steps:
s1, adding required purified water into a preparation tank, pouring 0.1% carbomer which is weighed into the preparation tank, uniformly stirring, heating the prepared solution to above 70 ℃, and preserving heat for 30min;
s2, gradually cooling, sequentially pouring 1% butanediol, 0.1% sodium hyaluronate, 0.1% p-hydroxyacetophenone, 0.1% polyglutamic acid, 0.1% hydrolyzed sclerotium gum, 0.05% vitamin E,0.1% tooth petal delay Hu Suogen extract, 0.1% safflower extract, 0.01% radix codonopsis extract, 0.01% angelica sinensis extract, 0.01% rhizoma ligustici wallichii root extract, 0.01% frankincense extract, 0.01% myrrh extract, 0.01% licorice extract, 0.01% verbena extract and the balance purified water, and uniformly stirring;
s3, further cooling and sequentially pouring weighed 0.01% of hydrolyzed collagen, 0.1% of palmitoyl pentapeptide-4, 0.1% of ascorbic acid, 0.1% of glycerol, 0.1% of mannans, 0.00% of vitamin B complex, 0.1% of triethanolamine and 0.00% of lavender oil, uniformly stirring, packaging and sealing to obtain the herbal alopecia preventing essence product with alopecia preventing effect.
Example 2
A preparation method of herbal anti-alopecia essence comprises the following steps:
s1, adding required purified water into a preparation tank, pouring 0.56% carbomer which is weighed into the preparation tank, uniformly stirring, heating the prepared solution to above 70 ℃, and preserving heat for 30min;
s2, gradually cooling, sequentially pouring 3.84% butanediol, 0.46% sodium hyaluronate, 0.49% p-hydroxyacetophenone, 0.67% polyglutamic acid, 0.72% hydrolyzed sclerotium gum, 0.34% vitamin E,0.66% tooth petal delay Hu Suogen extract, 0.62% safflower extract, 0.35% radix codonopsis extract, 0.51% angelica sinensis extract, 0.15% rhizoma ligustici wallichii root extract, 0.22% frankincense extract, 0.31% myrrh extract, 0.15% licorice extract, 0.27% verbena extract and the balance of purified water, and uniformly stirring;
s3, further cooling and sequentially pouring weighed 0.36% of hydrolyzed collagen, 0.69% of palmitoyl pentapeptide-4, 0.78% of ascorbic acid, 0.62% of glycerol, 0.27% of mannans, 0.03% of vitamin B complex, 0.67% of triethanolamine and 0.02% of lavender oil, uniformly stirring, packaging and sealing to obtain the herbal alopecia preventing essence product with alopecia preventing effect.
Example 3
A preparation method of herbal anti-alopecia essence comprises the following steps:
s1, adding required purified water into a preparation tank, pouring 1.05% carbomer which is weighed into the preparation tank, uniformly stirring, heating the prepared solution to above 70 ℃, and preserving heat for 30min;
s2, gradually cooling, sequentially pouring 5.5% butanediol, 1.05% sodium hyaluronate, 1.05% p-hydroxyacetophenone, 1.05% polyglutamic acid, 1.05% hydrolyzed sclerotium gum, 0.52% vitamin E,1.05% tooth petal delay Hu Suogen extract, 1.05% safflower extract, 0.51% radix codonopsis extract, 0.52% angelica sinensis extract, 0.48% rhizoma ligustici wallichii root extract, 0.46% frankincense extract, 0.53% myrrh extract, 0.52% licorice extract, 0.47% verbena extract and the balance of purified water, and uniformly stirring;
s3, further cooling and sequentially pouring weighed 0.54% of hydrolyzed collagen, 1.05% of palmitoyl pentapeptide-4, 1.05% of ascorbic acid, 1.05% of glycerol, 0.45% of manna, 0.05% of vitamin B complex, 1.05% of triethanolamine and 0.05% of lavender oil, uniformly stirring, packaging and sealing to obtain the herbal alopecia preventing essence product with alopecia preventing effect.
Example 4
A preparation method of herbal anti-alopecia essence comprises the following steps:
s1, adding required purified water into a preparation tank, pouring 1.52% carbomer which is weighed into the preparation tank, uniformly stirring, heating the prepared solution to above 70 ℃, and preserving heat for 30min;
s2, gradually cooling, sequentially pouring 7.68% butanediol, 1.62% sodium hyaluronate, 1.84% p-hydroxyacetophenone, 1.79% polyglutamic acid, 1.23% hydrolyzed sclerotium gum, 0.76% vitamin E,1.36% tooth petal delay Hu Suogen extract, 1.46% safflower extract, 0.67% radix codonopsis extract, 0.89% angelica sinensis extract, 0.92% rhizoma ligustici wallichii root extract, 0.67% frankincense extract, 0.59% myrrh extract, 0.66% licorice extract, 0.67% verbena extract and the balance of purified water, and uniformly stirring;
s3, further cooling and sequentially pouring weighed 0.75% of hydrolyzed collagen, 1.44% of palmitoyl pentapeptide-4, 1.26% of ascorbic acid, 1.85% of glycerol, 0.51% of manna, 0.08% of vitamin B complex, 1.37% of triethanolamine and 0.09% of lavender oil, uniformly stirring, packaging and sealing to obtain the herbal alopecia preventing essence product with alopecia preventing effect.
Example 5
A preparation method of herbal anti-alopecia essence comprises the following steps:
s1, adding required purified water into a preparation tank, pouring 2% carbomer which is weighed into the preparation tank, uniformly stirring, heating the prepared solution to above 70 ℃, and preserving heat for 30min;
s2, gradually cooling, sequentially pouring 10% butanediol, 2% sodium hyaluronate, 2% p-hydroxyacetophenone, 2% polyglutamic acid, 2% hydrolyzed sclerotium gum, 1% vitamin E,2% tooth petal delay Hu Suogen extract, 2% safflower extract, 1% radix codonopsis extract, 1% angelica sinensis extract, 1% rhizoma ligustici wallichii root extract, 1% frankincense extract, 1% myrrh extract, 1% licorice extract, 1% verbena extract and the balance of purified water, and uniformly stirring;
s3, further cooling and sequentially pouring the weighed 1% hydrolyzed collagen, 2% palmitoyl pentapeptide-4, 2% ascorbic acid, 2% glycerol, 1% manna, 0.1% vitamin B complex, 2% triethanolamine and 0.1% lavender oil into the mixture, uniformly stirring the mixture, packaging the mixture, and sealing the package to obtain the herbal alopecia preventing essence product with the alopecia preventing effect.
Product security
(1) The product of the invention entrusts a third party detection mechanism to carry out security inspection according to cosmetic security technical Specification (2015 edition), and the result is as follows:
(1) and (3) microorganism detection, namely, the total number of colonies, the total number of moulds and yeasts, the heat-resistant coliform group, staphylococcus aureus and pseudomonas aeruginosa meet the requirement of cosmetic safety technical Specification (2015 edition) on microorganism indexes.
(2) Physical and chemical inspection: the test results of mercury, lead, arsenic, cadmium and dioxane meet the requirements of cosmetic safety technical Specification (2015 edition).
(3) Toxicology test:
a. results of multiple skin irritation tests: has no irritation.
b. Skin allergy test results: skin allergies were not seen.
c. Skin phototoxicity test results: no skin phototoxicity was seen.
d. Bacterial back mutation assay results: the test substance showed no mutagenicity with and without S9.
e. In vitro mammalian cell chromosomal aberration test results: negative.
(2) The product of the invention entrusts a third party detection mechanism to carry out human body trial experiments according to cosmetic safety technical Specification (2015 edition), and the results are as follows: a total of 30 subjects completed the test, and skin adverse reaction was found in 0 out of 30 subjects with reference to the human body safety test skin adverse reaction classification standard specified in the 2015 edition of "cosmetic safety technical Specification".
The test results show that the product safety is qualified and has no stimulation to human body safety.
Product availability
The product of the invention entrusts a third party detection mechanism to test the alopecia preventing effect, 60 subjects continue to use the product of the invention for 12 weeks, the alopecia count and the hair density are counted and evaluated, and the change of the tested parts before the use, 4 weeks, 8 weeks and 12 weeks of the use of the product is detected.
The detection result shows that:
(1) after trial of the test product, the improvement degree of the alopecia count of the test product group is obviously better than that of the negative control group (p < 0.05) at each return visit time point;
(2) after trial of the test product, the improvement degree of the local hair density of the test product group has no significant difference (p is more than or equal to 0.05) compared with that of the negative control group at each return visit time point;
(3) after trial of the test product, the overall hair density improvement of the test product group was significantly better than that of the negative control group (p < 0.05) at 12 weeks of return visit after use;
in conclusion, under the test conditions, the test product has the anti-falling effect.
The technical scope of the present invention is not limited to the above description, and those skilled in the art may make various changes and modifications to the above-described embodiments without departing from the technical spirit of the present invention, and these changes and modifications should be included in the scope of the present invention.
Claims (8)
1. The herbal alopecia preventing essence is characterized by comprising, by mass, 0.27-11.10% of plant extracts, 0.26-6.10% of nutrient elements, 1.51-21.00% of moisturizers and the balance of water;
the plant extract comprises extract of herba Apocyni Veneti Hu Suogen, carthami flos extract, radix Codonopsis Lanceolatae extract, radix Angelicae sinensis extract, rhizoma Ligustici Chuanxiong root extract, olibanum extract, myrrha extract, glycyrrhrizae radix extract, herba Verbenae extract, and oleum Lavandula Angustifolia.
2. The herbal anti-baldness essence according to claim 1, wherein the plant extract comprises, in mass fraction, 0.1-2% of a tooth petal extract Hu Suogen extract, 0.1-2% of a safflower extract, 0.01-1% of a radix codonopsitis extract, 0.01-1% of an angelica extract, 0.01-1% of a rhizome of chuanxiong extract, 0.01-1% of a olibanum extract, 0.01-1% of a myrrh extract, 0.01-1% of a licorice extract, 0.01-1% of a verbena extract and 0.001-0.1% of lavender oil.
3. The herbal anti-baldness essence according to claim 1, wherein the nutrient elements comprise, in mass fraction, 0.1-2% sodium hyaluronate, 0.05-1% vitamin E,0.1-2% palmitoyl pentapeptide-4, 0.01-1% mannan and 0.001-0.1% vitamin B complex.
4. The herbal anti-baldness concentrate of claim 3, wherein said vitamin B complex comprises biotin, folic acid, vitamin B12, vitamin B3, pantothenic acid, vitamin B6, vitamin B2, vitamin B1, and yeast polypeptides.
5. The herbal anti-baldness essence according to claim 1, wherein the humectant comprises 1-10% butanediol, 0.1-2% polyglutamic acid, 0.1-2% hydrolyzed sclerotium rolfsii, 0.01-1% hydrolyzed collagen, 0.1-2% ascorbic acid, 0.1-2% glycerol and 0.1-2% triethanolamine by mass fraction.
6. The herbal anti-baldness concentrate of claim 1, further comprising 0.1-2% by mass of a thickener which is carbomer.
7. The herbal anti-baldness essence according to claim 1, further comprising 0.1-2% by mass of a preservative which is p-hydroxyacetophenone.
8. The preparation method of the herbal alopecia preventing essence is characterized by comprising the following steps of:
s1, adding required purified water into a preparation tank, pouring weighed A-phase raw materials into the preparation tank, uniformly stirring, heating the prepared solution to above 70 ℃, and preserving heat for 30min; the A phase raw material comprises carbomer;
s2, gradually cooling, sequentially pouring the weighed B-phase raw materials, the weighed C-phase raw materials and the balance of purified water, and uniformly stirring;
the B phase raw materials comprise butanediol, sodium hyaluronate, p-hydroxyacetophenone, polyglutamic acid, hydrolyzed sclerotium rolfsii and vitamin E;
the C phase material comprises tooth petal Hu Suogen extract, carthami flos extract, radix Codonopsis Lanceolatae extract, radix Angelicae sinensis extract, rhizoma Ligustici Chuanxiong root extract, olibanum extract, myrrha extract, glycyrrhrizae radix extract, and herba Verbenae extract;
s3, further cooling, sequentially pouring the weighed D-phase raw materials and the weighed E-phase raw materials, uniformly stirring, packaging and sealing to obtain a herbal alopecia-preventing essence finished product with a alopecia-preventing effect;
the phase D comprises hydrolyzed collagen, palmitoyl pentapeptide-4, ascorbic acid, glycerol, mannans and vitamin B complex;
the E phase comprises triethanolamine and lavender oil.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310052278.2A CN116350553A (en) | 2023-02-02 | 2023-02-02 | Herbal alopecia preventing essence and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310052278.2A CN116350553A (en) | 2023-02-02 | 2023-02-02 | Herbal alopecia preventing essence and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116350553A true CN116350553A (en) | 2023-06-30 |
Family
ID=86938496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310052278.2A Pending CN116350553A (en) | 2023-02-02 | 2023-02-02 | Herbal alopecia preventing essence and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116350553A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1899596A (en) * | 2006-07-19 | 2007-01-24 | 张毅 | Chinese medicine preparation for preventing and controlling baldness and its preparing method |
CN110237015A (en) * | 2019-07-17 | 2019-09-17 | 厦门淳草生物科技有限公司 | A kind of nutrition Essence |
CN115414294A (en) * | 2022-09-06 | 2022-12-02 | 南京天其美生物技术有限公司 | Herbal soothing repair essence and preparation method thereof |
-
2023
- 2023-02-02 CN CN202310052278.2A patent/CN116350553A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1899596A (en) * | 2006-07-19 | 2007-01-24 | 张毅 | Chinese medicine preparation for preventing and controlling baldness and its preparing method |
CN110237015A (en) * | 2019-07-17 | 2019-09-17 | 厦门淳草生物科技有限公司 | A kind of nutrition Essence |
CN115414294A (en) * | 2022-09-06 | 2022-12-02 | 南京天其美生物技术有限公司 | Herbal soothing repair essence and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
南京天其美生物技术有限公司: "天其美头皮精华液", Retrieved from the Internet <URL:https://hzpba.nmpa.gov.cn/gccx/chakan.html?prodId=1148209017852526592&gb=G> * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106177408B (en) | Skin anti-allergy traditional Chinese medicine composition, traditional Chinese medicine preparation, mask and preparation method | |
CN110882207B (en) | Preparation process and method of essence for skin repair | |
CN112618456B (en) | Oil control convergence suit and use method thereof | |
CN108452275A (en) | It is a kind of to have effects that the composition, medicament and preparation method of relaxing tendons and activating collaterals | |
CN102614102A (en) | Dandruff-removing medicinal composition and preparation method thereof | |
CN112426390A (en) | Natural traditional Chinese medicine acne-removing composition and preparation method thereof | |
CN111617197A (en) | Traditional Chinese medicine composition for hair growth and hair nourishing, and preparation method and application thereof | |
CN105998617B (en) | External traditional Chinese medicine extract with effect of relieving senile skin itch and preparation method and application thereof | |
CN108464961B (en) | Natural plant shampoo and preparation method thereof | |
CN106039022B (en) | Skin-brightening and whitening traditional Chinese medicine composition, skin-brightening and whitening traditional Chinese medicine preparation, skin-brightening and whitening mask and preparation method | |
CN116350563B (en) | Plant co-fermentation composition and preparation method and application thereof | |
CN107744569A (en) | A kind of Essence and preparation method thereof with hair care, hair tonic effect | |
CN101167834B (en) | Rosa xanthina dew tasty liquid and preparation method thereof | |
CN111568947A (en) | Preparation method of traditional Chinese medicine dandruff-removing and itching-relieving agent | |
CN115006336B (en) | Plant shampoo capable of preventing hair loss, strengthening hair, removing dandruff and relieving itching and preparation method thereof | |
CN116350553A (en) | Herbal alopecia preventing essence and preparation method thereof | |
CN110013462B (en) | Artemisia argyi paste for whitening and protecting skin and preparation method thereof | |
CN115414294A (en) | Herbal soothing repair essence and preparation method thereof | |
CN112516043A (en) | A Chinese medicinal shampoo with effects of blackening hair, promoting hair growth, relieving itching and removing dandruff | |
CN107854681A (en) | A kind of anti-inflammatory composition and preparation method thereof | |
CN112121135A (en) | Traditional Chinese medicine hair conditioner for scalp and hair care and preparation method thereof | |
CN110200877B (en) | Traditional Chinese medicine shampoo and preparation method thereof | |
CN114652763A (en) | Plant fermentation allergy-relieving composition and preparation method and application thereof | |
CN110801423A (en) | Hair nourishing water and preparation method thereof | |
CN112402356A (en) | Pure micro-ecological skin cooling and nursing mask containing Chinese herbal medicines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |